Global Needle-Free Drug Delivery Devices Market : Global Market Size, Industry Growth, Future Prospects, Opportunities and Forecast 2019-2025

The Global Needle-Free Drug Delivery Devices Market is expected to exhibit remarkable growth during the forecast period. The market for drug delivery devices is expanding continuously as inventors find new approaches to deliver biologics and, cell and gene therapies. The conventional method of delivering drugs to the body includes tablets, syrups and most commonly injections; however, tablets and syrups work slowly and can cause some side effects to the patients. In addition, patients don’t wish to take medications through oral route due to bitter taste of the medications. And injection is painful due to piercing of needle into the body that can even cause mortality if it is not injected properly or if same needle is used repeatedly. 

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/needle-free-drug-delivery-devices-market-size

Needlestick injury is also possible if a broken needle is left in the body, and it can cause infections and transmit diseases to human body. Keeping in mind these limitations of the conventional method of drug delivery, technologies have been advanced in the needle-free drug delivery devices industry in order to deliver drugs to patients with no pain. One of the advancements is the needle-free auto and pen injectors that are designed to deliver a single dose of a specific drug. Autoinjectors are easy to use and offer self-administration to the patients. These were designed to combat the hesitation regarding self-administration of needle-based medications. Advancement in auto-injector design helping pharmaceutical companies to market their drugs more effectively by helping patients to comply with their dosage prescriptions. 
Further, the players operating in the global needle-free drug delivery devices market are establishing collaborations to bring new devices into the market. For instance, In July 2018, PharmaJet and Mundipharma signed an agreement for marketing and distributing Tropis and Stratis needle-free drug-delivery devices of PharmaJet to more than 120 markets across the globe. The devices are designed for vaccine immunizations. This partnership focuses on providing access to this needle-free technology, to more patients, especially in the emerging economies where outbreaks typically occur.

Browse the full report description of Global Needle Free Drug Delivery Devices Market Size, Share & Trends Analysis Report, by Technology (Inhaler Technology, Jet Injectors, Transdermal Patch Technology, and Others), by Application (Vaccines Delivery, Pain Management, Insulin Delivery, Pediatric Injections, and Others), and Forecast 2019-2025 at  https://www.omrglobal.com/industry-reports/needle-free-drug-delivery-devices-market-size

PharmaJet's portfolio consists of:

Stratis IM/SC (Stratis) for intramuscular or subcutaneous delivery
Tropis ID (Tropis) for intradermal delivery of liquid medicines directly into the skin


Further, in October 2017, Takeda Pharmaceutical Co. Ltd. and Portal Instruments established a collaboration for the development and commercialization of Portal’s needle-free drug delivery device for potential use with Takeda’s investigational or approved biologic medicines. The Portal device is potentially used for applications across a wide range of biologic medicines that currently require administration through an injection.
Takeda in its first development program for potentially using this device would be for investigational use with Entyvio (vedolizumab). Entyvio is a monoclonal antibody used for adults living with moderately to severely active ulcerative colitis or Crohn’s disease. This antibody is currently administered through intravenous infusion. A Phase III clinical trial program is currently being in operation to evaluate the efficacy and safety of a subcutaneous formulation of vedolizumab in adults living with moderately to severely active ulcerative colitis or Crohn’s disease.

Visit here to know more about Global Needle Free Drug Delivery Devices Market study https://www.omrglobal.com/industry-reports/needle-free-drug-delivery-devices-market-size

Needle-Free Drug Delivery Devices Market Segmentation

By Technology
  • Inhaler Technology
  • Jet Injectors
  • Transdermal Patch Technology
  • Others Needle-free Technology

By Application 
  • Pain Management
  • Insulin delivery for Diabetes
  • Vaccines Delivery
  • Pediatric Injections
  • Others Applications

Needle-Free Drug Delivery Devices Market – Segment by Region 
North America 
  • United States
  • Canada
  • Europe

Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia-Pacific    
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
Rest of the World
  • Latin America
  • Middle East and Africa

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404

Comments

Popular posts from this blog

Information System Audit Services Market to Witness Robust Expansion by 2028

Impact of COVID-19 on Italy Ventilator Industry Share, Trends and Forecast to 2025

North American Electric Vehicle Charger Market Growth, Size, Share, Industry Report and Forecast to 2019-2025